Hong Kong stock market anomaly | Federal Pharmaceutical (03933.HK) rose nearly 3% in morning trading, the innovative drug TUL01101 tablet Phase II clinical trial met the standard and plans to conduct Phase III trial.

According to the "Securities Times" app, Federal Pharmaceutical (03933.HK) rose nearly 3% in early trading, with an increase of 2.32% as of press time, reaching 12.8 Hong Kong dollars, with a turnover of 64.0646 million Hong Kong dollars.